Microbot Medical Inc. (MBOT)
USD 0.97
(-3.69%)
USD 0.97
(-3.69%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 231 Thousand USD | -50.0% |
| 2022 | 462 Thousand USD | -32.06% |
| 2021 | 680 Thousand USD | -16.36% |
| 2020 | 813 Thousand USD | -9.97% |
| 2019 | 903 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 76 Thousand USD | -99.26% |
| 2015 | 10.33 Million USD | -31.2% |
| 2014 | 15.02 Million USD | 16.35% |
| 2013 | 12.9 Million USD | 3580.04% |
| 2012 | 350.78 Thousand USD | -35.1% |
| 2011 | 540.47 Thousand USD | -31.11% |
| 2010 | 784.57 Thousand USD | -22.61% |
| 2009 | 1.01 Million USD | -1.99% |
| 2008 | 1.03 Million USD | -12.94% |
| 2007 | 1.18 Million USD | -12.07% |
| 2006 | 1.35 Million USD | 337.52% |
| 2005 | 308.84 Thousand USD | -84.11% |
| 2004 | 1.94 Million USD | -6.86% |
| 2003 | 2.08 Million USD | -9.9% |
| 2002 | 2.31 Million USD | -11.1% |
| 2001 | 2.6 Million USD | -11.31% |
| 2000 | 2.93 Million USD | -9.94% |
| 1999 | 3.26 Million USD | -36.05% |
| 1998 | 5.1 Million USD | -1.92% |
| 1997 | 5.2 Million USD | -44.68% |
| 1996 | 9.4 Million USD | 44.62% |
| 1995 | 6.5 Million USD | -1.52% |
| 1994 | 6.6 Million USD | 60.98% |
| 1993 | 4.1 Million USD | -8.89% |
| 1992 | 4.5 Million USD | 309.09% |
| 1991 | 1.1 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 208 Thousand USD | -9.96% |
| 2024 Q2 | 148 Thousand USD | -28.85% |
| 2023 Q4 | 231 Thousand USD | -5.71% |
| 2023 Q2 | 317 Thousand USD | -19.34% |
| 2023 Q1 | 393 Thousand USD | -14.94% |
| 2023 FY | 231 Thousand USD | -50.0% |
| 2023 Q3 | 245 Thousand USD | -22.71% |
| 2022 Q4 | 462 Thousand USD | -8.33% |
| 2022 Q1 | 702 Thousand USD | 3.24% |
| 2022 FY | 462 Thousand USD | -32.06% |
| 2022 Q3 | 504 Thousand USD | -12.04% |
| 2022 Q2 | 573 Thousand USD | -18.38% |
| 2021 Q2 | 708 Thousand USD | -4.07% |
| 2021 Q1 | 738 Thousand USD | -9.23% |
| 2021 FY | 680 Thousand USD | -16.36% |
| 2021 Q4 | 680 Thousand USD | -3.27% |
| 2021 Q3 | 703 Thousand USD | -0.71% |
| 2020 FY | 813 Thousand USD | -9.97% |
| 2020 Q2 | 855 Thousand USD | -1.61% |
| 2020 Q3 | 813 Thousand USD | -4.91% |
| 2020 Q1 | 869 Thousand USD | -3.77% |
| 2020 Q4 | 813 Thousand USD | 0.0% |
| 2019 Q2 | 492 Thousand USD | -12.46% |
| 2019 Q3 | 445 Thousand USD | -9.55% |
| 2019 Q1 | 562 Thousand USD | 0.0% |
| 2019 FY | 903 Thousand USD | 0.0% |
| 2019 Q4 | 903 Thousand USD | 102.92% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 FY | - USD | -100.0% |
| 2017 Q1 | 245 Thousand USD | 222.37% |
| 2016 FY | 76 Thousand USD | -99.26% |
| 2016 Q1 | 9.3 Million USD | -9.96% |
| 2016 Q2 | 1206.28 USD | -99.99% |
| 2016 Q4 | 76 Thousand USD | -96.2% |
| 2016 Q3 | 2 Million USD | 165699.4% |
| 2015 FY | 10.33 Million USD | -31.2% |
| 2015 Q1 | 13.39 Million USD | -10.81% |
| 2015 Q2 | 12.42 Million USD | -7.23% |
| 2015 Q3 | 11.4 Million USD | -8.2% |
| 2015 Q4 | 10.33 Million USD | -9.42% |
| 2014 Q2 | 14.99 Million USD | -6.03% |
| 2014 Q4 | 15.02 Million USD | -5.94% |
| 2014 Q1 | 15.96 Million USD | 23.64% |
| 2014 FY | 15.02 Million USD | 16.35% |
| 2014 Q3 | 15.96 Million USD | 6.47% |
| 2013 Q3 | 13.7 Million USD | 39.35% |
| 2013 Q4 | 12.9 Million USD | -5.79% |
| 2013 FY | 12.9 Million USD | 3580.04% |
| 2013 Q1 | 299.1 Thousand USD | -14.73% |
| 2013 Q2 | 9.83 Million USD | 3187.63% |
| 2012 Q2 | 430 Thousand USD | -9.71% |
| 2012 Q3 | 402.43 Thousand USD | -6.41% |
| 2012 Q4 | 350.78 Thousand USD | -12.83% |
| 2012 FY | 350.78 Thousand USD | -35.1% |
| 2012 Q1 | 476.25 Thousand USD | -11.88% |
| 2011 Q3 | 604.33 Thousand USD | -9.33% |
| 2011 Q1 | 725.74 Thousand USD | -7.5% |
| 2011 Q4 | 540.47 Thousand USD | -10.57% |
| 2011 FY | 540.47 Thousand USD | -31.11% |
| 2011 Q2 | 666.49 Thousand USD | -8.16% |
| 2010 Q1 | 955.36 Thousand USD | -5.77% |
| 2010 FY | 784.57 Thousand USD | -22.61% |
| 2010 Q4 | 784.57 Thousand USD | -6.93% |
| 2010 Q3 | 843 Thousand USD | -6.31% |
| 2010 Q2 | 899.79 Thousand USD | -5.82% |
| 2009 Q1 | 1.13 Million USD | 10.09% |
| 2009 FY | 1.01 Million USD | -1.99% |
| 2009 Q4 | 1.01 Million USD | -5.41% |
| 2009 Q3 | 1.07 Million USD | -5.03% |
| 2009 Q2 | 1.12 Million USD | -0.9% |
| 2008 Q1 | 1.15 Million USD | -3.09% |
| 2008 FY | 1.03 Million USD | -12.94% |
| 2008 Q4 | 1.03 Million USD | -3.79% |
| 2008 Q3 | 1.07 Million USD | -3.54% |
| 2008 Q2 | 1.11 Million USD | -3.2% |
| 2007 Q1 | 1.28 Million USD | -4.81% |
| 2007 Q2 | 1.27 Million USD | -1.08% |
| 2007 FY | 1.18 Million USD | -12.07% |
| 2007 Q4 | 1.18 Million USD | -3.0% |
| 2007 Q3 | 1.22 Million USD | -3.73% |
| 2006 Q1 | 1.59 Million USD | 417.28% |
| 2006 Q3 | 1.41 Million USD | -7.74% |
| 2006 FY | 1.35 Million USD | 337.52% |
| 2006 Q2 | 1.53 Million USD | -3.91% |
| 2006 Q4 | 1.35 Million USD | -4.59% |
| 2005 Q1 | 1.87 Million USD | -3.73% |
| 2005 FY | 308.84 Thousand USD | -84.11% |
| 2005 Q2 | 1.79 Million USD | -3.91% |
| 2005 Q4 | 308.84 Thousand USD | -82.07% |
| 2005 Q3 | 1.72 Million USD | -4.19% |
| 2004 Q1 | 2.02 Million USD | -2.82% |
| 2004 FY | 1.94 Million USD | -6.86% |
| 2004 Q2 | 1.96 Million USD | -2.9% |
| 2004 Q3 | 1.9 Million USD | -3.03% |
| 2004 Q4 | 1.94 Million USD | 1.78% |
| 2003 Q4 | 2.08 Million USD | -2.74% |
| 2003 Q1 | 2.25 Million USD | -2.43% |
| 2003 Q3 | 2.14 Million USD | -2.63% |
| 2003 Q2 | 2.2 Million USD | -2.49% |
| 2003 FY | 2.08 Million USD | -9.9% |
| 2002 Q1 | 2.52 Million USD | -3.21% |
| 2002 FY | 2.31 Million USD | -11.1% |
| 2002 Q4 | 2.31 Million USD | -2.37% |
| 2002 Q3 | 2.37 Million USD | -2.68% |
| 2002 Q2 | 2.43 Million USD | -3.32% |
| 2001 Q3 | 2.68 Million USD | -3.01% |
| 2001 Q4 | 2.6 Million USD | -3.11% |
| 2001 FY | 2.6 Million USD | -11.31% |
| 2001 Q1 | 2.85 Million USD | -2.81% |
| 2001 Q2 | 2.77 Million USD | -2.89% |
| 2000 Q1 | 3.18 Million USD | -2.45% |
| 2000 FY | 2.93 Million USD | -9.94% |
| 2000 Q2 | 3.1 Million USD | -2.51% |
| 2000 Q3 | 3.01 Million USD | -2.63% |
| 2000 Q4 | 2.93 Million USD | -2.73% |
| 1999 Q4 | 3.26 Million USD | -4.08% |
| 1999 Q1 | 3.2 Million USD | -37.25% |
| 1999 FY | 3.26 Million USD | -36.05% |
| 1999 Q2 | 4.2 Million USD | 31.25% |
| 1999 Q3 | 3.4 Million USD | -19.05% |
| 1998 Q4 | 5.1 Million USD | -5.56% |
| 1998 Q2 | 6.1 Million USD | 24.49% |
| 1998 Q1 | 4.9 Million USD | -5.77% |
| 1998 FY | 5.1 Million USD | -1.92% |
| 1998 Q3 | 5.4 Million USD | -11.48% |
| 1997 FY | 5.2 Million USD | -44.68% |
| 1997 Q2 | 8.8 Million USD | -3.3% |
| 1997 Q3 | 8.6 Million USD | -2.27% |
| 1997 Q4 | 5.2 Million USD | -39.53% |
| 1997 Q1 | 9.1 Million USD | -3.19% |
| 1996 FY | 9.4 Million USD | 44.62% |
| 1996 Q4 | 9.4 Million USD | 10.59% |
| 1996 Q3 | 8.5 Million USD | 23.19% |
| 1996 Q1 | 6.3 Million USD | -3.08% |
| 1996 Q2 | 6.9 Million USD | 9.52% |
| 1995 Q2 | 6.3 Million USD | -1.56% |
| 1995 FY | 6.5 Million USD | -1.52% |
| 1995 Q4 | 6.5 Million USD | 6.56% |
| 1995 Q3 | 6.1 Million USD | -3.17% |
| 1995 Q1 | 6.4 Million USD | -3.03% |
| 1994 Q1 | 4 Million USD | -2.44% |
| 1994 Q4 | 6.6 Million USD | 43.48% |
| 1994 Q3 | 4.6 Million USD | 4.55% |
| 1994 Q2 | 4.4 Million USD | 10.0% |
| 1994 FY | 6.6 Million USD | 60.98% |
| 1993 Q2 | 4.3 Million USD | -2.27% |
| 1993 Q4 | 4.1 Million USD | 0.0% |
| 1993 FY | 4.1 Million USD | -8.89% |
| 1993 Q1 | 4.4 Million USD | -2.22% |
| 1992 Q4 | 4.5 Million USD | 0.0% |
| 1992 FY | 4.5 Million USD | 309.09% |
| 1991 Q4 | 1.1 Million USD | 0.0% |
| 1991 FY | 1.1 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 99.73% |
| AngioDynamics, Inc. | 5.91 Million USD | 96.094% |
| AtriCure, Inc. | 74.49 Million USD | 99.69% |
| Avinger, Inc. | 15.39 Million USD | 98.5% |
| Azenta, Inc. | 60.43 Million USD | 99.618% |
| BioLife Solutions, Inc. | 42.69 Million USD | 99.459% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 99.991% |
| Daxor Corporation | 755.65 Thousand USD | 69.431% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | 96.777% |
| Femasys Inc. | 6.7 Million USD | 96.553% |
| GlucoTrack, Inc. | 196 Thousand USD | -17.857% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 99.46% |
| Hologic, Inc. | 2.53 Billion USD | 99.991% |
| ICU Medical, Inc. | 1.7 Billion USD | 99.986% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 99.743% |
| KORU Medical Systems, Inc. | 4.44 Million USD | 94.803% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | 98.79% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 99.976% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | 96.849% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 99.974% |
| Nephros, Inc. | 1.83 Million USD | 87.418% |
| NovoCure Limited | 596.24 Million USD | 99.961% |
| NEXGEL, Inc. | 2.79 Million USD | 91.744% |
| NEXGEL, Inc. | 2.79 Million USD | 91.744% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 99.693% |
| OraSure Technologies, Inc. | 13.5 Million USD | 98.289% |
| Pro-Dex, Inc. | 13.54 Million USD | 98.295% |
| Pulse Biosciences, Inc. | 9.14 Million USD | 97.474% |
| Predictive Oncology Inc. | 2.85 Million USD | 91.914% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | 93.274% |
| QuidelOrtho Corporation | 2.61 Billion USD | 99.991% |
| Repligen Corporation | 711.8 Million USD | 99.968% |
| Sanara MedTech Inc. | 11.79 Million USD | 98.041% |
| STAAR Surgical Company | 35.83 Million USD | 99.355% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | 32.456% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.99% |
| Jin Medical International Ltd. | 4.11 Million USD | 94.384% |